Digest Network Come funziona
Network
/
Società
Be
Non verificato

BeOne Medicines Ltd.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieOncologiaSalute

55 comunicati stampa

Guarda tutti i comunicati
01/09/2026
BeOne Medicines to Present at the Morgan Stanley Annual Global Healthcare Conference
Fonte
BeOne Medicines Ltd.
Emittente
Business Wire
1.00
0
31/08/2026
Industria
Oncologia
Salute
Medicina - Varie
Sanità
Farmaceutica
Biotecnologia
BeOne Medicines Announces New Phase 3 Survival Data Reinforcing Benefit of ZIIHERA-Containing Regimens in First-Line HER2+ Gastroesophageal Cancer
Fonte
BeOne Medicines Ltd.
Emittente
Business Wire
1.00
0
25/08/2026
Industria
Biotecnologia
Sanità
Salute
Farmaceutica
Oncologia
BeOne Medicines Announces U.S. FDA Approval for TEVIMBRA-Based Regimen for First-Line HER2+ GEA
Fonte
BeOne Medicines Ltd.
Emittente
Business Wire
1.00
0
18/08/2026
Mercato del lavoro
Volontariato/Solidarietà/Non profit
Industria
Oncologia
Associazioni/Professionisti
Salute
Farmaceutica
Biotecnologia
BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries
Fonte
BeOne Medicines Ltd.
Emittente
Business Wire
1.00
0
10/08/2026
Mercato del lavoro
Industria
Scienza
Medicina - Varie
Sanità
Biotecnologia
Farmaceutica
Salute
Oncologia
BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration
Fonte
BeOne Medicines Ltd.
Emittente
Business Wire
1.00
0
05/08/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Oncologia
Salute
Scienza
Farmaceutica
Biotecnologia
BeOne Medicines Announces Second Quarter 2026 Financial Results and Business Updates
Fonte
BeOne Medicines Ltd.
Emittente
Business Wire
1.00
0
23/07/2026
Multimedialità
Scienza
Biotecnologia
Farmaceutica
Oncologia
Sanità
Salute
Medicina - Varie
BeOne Medicines Expands U.S. Manufacturing with Total Investment of More Than $1 Billion to Advance Innovative Cancer Medicines
Fonte
BeOne Medicines Ltd.
Emittente
Business Wire
1.00
0
17/07/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Oncologia
BeOne Medicines to Announce Second Quarter 2026 Financial Results on August 5
Fonte
BeOne Medicines Ltd.
Emittente
Business Wire
1.00
0
30/06/2026
Scienza
Igiene alimentare
Medicina - Varie
Biotecnologia
Sanità
Farmaceutica
Salute
Oncologia
Industria
BeOne Medicines Announces Positive Phase 3 Results for BRUKINSA in Frontline Mantle Cell Lymphoma
Fonte
BeOne Medicines Ltd.
Emittente
Business Wire
1.00
0
12/06/2026
Eventi
Industria
Oncologia
Salute
Igiene alimentare
Medicina - Varie
Farmaceutica
Biotecnologia
BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 2026
Fonte
BeOne Medicines Ltd.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0